Literature DB >> 12706355

Geriatric oncology: a clinical approach to the older patient with cancer.

L Repetto1, A Venturino, L Fratino, D Serraino, G Troisi, W Gianni, M Pietropaolo.   

Abstract

Due to the ageing of the population and the sharp increase in life expectancy, cancer in the older person has become an increasingly common problem in the Western world. Although several authors have stressed that elderly cancer patients deserve special attention as a target group for research efforts, older aged patients are still less likely to be offered participation in clinical trials. The cellular and molecular mechanisms regulating the physiological process of ageing and senescence are far from understood, although inflammation is likely to play an important role, at least in some cancers. In addition, the relationship between ageing and cancer risk is also far from understood. One of the most intriguing aspects of ageing is how different the ageing process is from person to person; the basis for this variation is largely unknown. Population-based studies and longitudinal surveys have shown that comorbidity and physical and mental functioning are important risk factors; thus, a meaningful assessment of comorbidity and disability should be implemented in clinical practice. Modern geriatrics is targeted towards patients with multiple problems. Such patients are not simply old, but are geriatric patients because of interacting psychosocial and physical problems. As a consequence, the health status of old persons cannot be evaluated by merely describing the single disease, and/or by measuring the response, or survival after treatment. Conversely, it is necessary to conduct a more comprehensive investigation of the 'functional status' of the aged person. A geriatric consultation provides a variety of relevant information and enables the healthcare team to manage the complexity of health care in the elderly; this process is referred to as the Comprehensive Geriatric Assessment (CGA). The use of CGA is now being introduced into oncological practice. The definition of frailty is still controversial and represents a major issue of debate in clinical geriatrics. As the frail population increases, clinical trials in frail persons are needed. The usefulness of these trials requires a consensus as to the definition of frailty. Clearly, the management of older persons with cancer requires the acquisition of special skills in the evaluation of the older person and in the recognition and management of emergencies as well as experience in geriatric case management.

Entities:  

Mesh:

Year:  2003        PMID: 12706355     DOI: 10.1016/s0959-8049(03)00062-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  36 in total

1.  Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.

Authors:  Wesam A Nasif; Mahmoud Lotfy; Ibrahim H El-Sayed; Ayman El-Meghawry El-Kenawy; Mohamed El-Shahat; Nabil Gad El-Hak
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Non-Hodgkin's lymphoma in the elderly.

Authors:  Paolo F Caimi; Paul M Barr; Nathan A Berger; Hillard M Lazarus
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

Review 3.  [Geriatric assessment of patients with hematological neoplasms].

Authors:  Benedikt Hofer; Laurenz Nagl; Florian Hofer; Reinhard Stauder
Journal:  Z Gerontol Geriatr       Date:  2017-03-31       Impact factor: 1.281

Review 4.  Are gold standard depression measures appropriate for use in geriatric cancer patients? A systematic evaluation of self-report depression instruments used with geriatric, cancer, and geriatric cancer samples.

Authors:  Christian J Nelson; Christina Cho; Alexandra R Berk; Jimmie Holland; Andrew J Roth
Journal:  J Clin Oncol       Date:  2009-12-07       Impact factor: 44.544

5.  Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.

Authors:  Anne Katrin Berger; Stefanie Zschaebitz; Christine Komander; Dirk Jäger; Georg Martin Haag
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

Review 6.  Targeted therapy for advanced hepatocellular cancer in the elderly: focus on sorafenib.

Authors:  D Germano; V Tinessa; E Barletta; L Cannella; B Daniele
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

7.  Impact of radiotherapy on the quality of life of elderly patients with localized breast cancer. A prospective study.

Authors:  Juan Ignacio Arraras; Ana Manterola; Miguel Angel Domínguez; Fernando Arias; Elena Villafranca; Pilar Romero; Enrique Martínez; José Juan Illarramendi; Esteban Salgado
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

Review 8.  Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.

Authors:  Paola Tomassetti; Teresa Salomone; Marina Migliori; Davide Campana; Roberto Corinaldesi
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Prognostic factors in 165 elderly colorectal cancer patients.

Authors:  Ke-Jun Nan; Hai-Xia Qin; Guang Yang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

10.  An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics.

Authors:  Jie-Kai Yu; Yi-Ding Chen; Shu Zheng
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.